A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...

GLP-1 receptor agonists affect sexual function differently across individuals and influencing libido and hormone levels in ...

Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.

In a phase 2 trial, firsekibart — an IL-1 beta antibody — outperforms colchicine in preventing acute gout flares over 12 ...

Diagnostic delays stem from uneven access to specialist testing, lack of reliable biomarkers, and symptom overlap with common mental health and attention disorders.

The increasing frequency of extreme weather events and continued rise in global temperatures may affect neurodevelopment in ...

Older, impulsive teens with prior substance use are more likely to be open to vaping or smoking, while strong parental ...

An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...

Individuals with systemic sclerosis have a higher risk for hematologic malignancies than those without the condition, with ...

A meta-analysis shows varying effectiveness of treatments in restoring smell in patients with chronic rhinosinusitis with ...

The global psoriasis burden shows a slight increase from 1990 to 2021 and is projected to rise further by 2050.